The LDN Book 3

Written by Medical Professionals, learn how Low Dose Naltrexone (LDN) can help with COVID and prolonged COVID, viruses, mold, CIRS, disease, cancer and more.The LDN Book 3, the 3rd in the series following on from the success of Books 1 & 2, includes:Pharmacology and Best Clinical Practices, Drug-Resistant Depression, Virally Damaged Tissues (including COVID-19, Herpes Simplex (HSV 1 & 2), Varicella-Zoster, Human Parvovirus B19 (B19V), Epstein-Barr (EBV), LDN and Longevity, Mixed Connective Tissue Disease (MCTD), Mold Illness and CIRS, Ophthalmic Conditions, Long COVID, Cancer, and Case Studies, Dosing Protocols with pages of references!Authors include Pharmacist Stephen Dickson, Dr. Elizabeth Livengood. Dr. Sarah Zielsdorf. Dr. Yusuf M. (JP) Saleeby, Dr. Deanna Windham, Dr. Kent Holtorf, Pharmacist Sebastian Denison. Professor Angus Dalgleish, Dr. Wai Liu, and Dr. Nasha WintersAutoimmune Diseases, Cancers, Chronic Pain, etc have high levels of inflammation.Best Seller Author Dr. Pamela W. Smith, MD, MPH, MS said "The great news is that inflammation can be balanced using many modalities from traditional medications to changing eating habits, to adding nutrients and herbal therapies, along with the newest treatment, Low Dose Naltrexone. LDN is a prescription compounded medication that very effectively reduces inflammation.Low Dose Naltrexone has been shown to be one of the keys to the future of medicine for many disease processes that are inflammatory in nature. It is also an efficacious pain control agent.It is my hope, and the hope of the world-class authors of this book, that you begin your medical journey toward healing by learning more about this wonderful medication".

© 2023 LDN Research Trust (Libro electrónico): 9781739107017

Fecha de lanzamiento

Libro electrónico: 6 de marzo de 2023